<DOC>
	<DOCNO>NCT00177086</DOCNO>
	<brief_summary>This study assess improvement percentage spontaneous stone passage distal ureteral calculus alfuzosin compare placebo , decrease pain narcotic/analgesic use associate stone passage , decrease time spontaneous stone passage , shift size distribution stone pass towards large size .</brief_summary>
	<brief_title>Alfuzosin Hydrochloride Promote Passage Distal Ureteral Calculi</brief_title>
	<detailed_description />
	<mesh_term>Calculi</mesh_term>
	<mesh_term>Kidney Calculi</mesh_term>
	<mesh_term>Nephrolithiasis</mesh_term>
	<mesh_term>Ureteral Calculi</mesh_term>
	<mesh_term>Ureterolithiasis</mesh_term>
	<mesh_term>Alfuzosin</mesh_term>
	<criteria>Age = &gt; 18 &lt; 8mm ureteral calculus pelvic brim identify noncontrast CT scan and/or intravenous pyelogram Subject know hypersensitivity Alfuzosin hydrochloride component Alfuzosin hydrochloride tablet Pregnant/Nursing female Solitary kidney Renal insufficiency ( Creatinine &gt; 1.8 ) Urinary infection ( fever &gt; 101 , positive urine culture , many bacteria urinalysis ) Moderate severe hepatic insufficiency ( ChildsPugh category B C ) Potent CYP3A4 inhibitor ketoconazole , itraconazole , ritonavir , since Alfuzosin blood level increase Other alphablockers Phosphodiesterase type 5 inhibitor erectile dysfunction Any subject principal investigator feel would best interest participate study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2013</verification_date>
</DOC>